The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CheckMate 649: A randomized, multicenter, open-label, phase 3 study of nivolumab (nivo) + ipilimumab (ipi) or nivo + chemotherapy (CTX) vs CTX alone in pts with previously untreated advanced (adv) gastric (G) or gastroesophageal junction (GEJ) cancer.
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; German Cancer Society; Merck Serono; Nordic Bioscience; Roche
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly; Pfizer
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Genentech; Lilly; Roche
 
Antoine Adenis
No Relationships to Disclose
 
Jean-Sebastien Aucoin
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Lilly
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Research Funding - Amgen; Bristol-Myers Squibb
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Ian Chau
Honoraria - Amgen; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi
 
James M. Cleary
Honoraria - Agios
Research Funding - Merck
Travel, Accommodations, Expenses - Roche
 
Kynan Tadao Feeney
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Fabio A. Franke
No Relationships to Disclose
 
Guillermo Ariel Mendez
No Relationships to Disclose
 
Michael Schenker
Research Funding - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Pfizer; Roche
 
Mingshun Li
Employment - Bristol-Myers Squibb
 
Erika Hitre
No Relationships to Disclose
 
Felix Couture
No Relationships to Disclose
 
Michalis Karamouzis
No Relationships to Disclose
 
Pierre-Luc Etienne
No Relationships to Disclose
 
Jaffer A. Ajani
Honoraria - Bayer; Five Prime Therapeutics; Genentech; Lilly/ImClone; Novartis; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; MedImmune; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
Travel, Accommodations, Expenses - Bayer; Five Prime Therapeutics; Novartis